S. Bianchi

发表

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

J. Skehel, D. Jarrossay, F. Sallusto, 2011, Science.

A LAIR-1 insertion generates broadly reactive antibodies against malaria variant antigens

Juliana K. Wambua, K. Marsh, R. Geiger, 2015, Nature.

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

Amalio Telenti, Katja Fink, Young-Jun Park, 2020, bioRxiv.

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Amalio Telenti, Katja Fink, Young-Jun Park, 2020, Nature.

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

A. Telenti, L. Purcell, J. Martinez-Picado, 2021, Nature.

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Beltramello, M. Diamond, R. Spreafico, 2020, Science.

RETRACTED: Role of the SEL1L:LC3-I Complex as an ERAD Tuning Receptor in the Mammalian ER

Riccardo Bernasconi, M. Molinari, C. Galli, 2012, Molecular Cell.

Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer

U. Baxa, R. Geiger, F. Sallusto, 2016, Nature Microbiology.

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential

M. Beltramello, A. Cavalli, E. Harris, 2017, Cell.

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

L. Purcell, B. Weynand, A. Walls, 2022, Science.

An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV

M. Humbert, J. Heeney, F. Sallusto, 2011, PloS one.

The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice

A. Telenti, L. Purcell, D. Belnap, 2022, bioRxiv.

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

A. Telenti, R. Spreafico, L. Purcell, 2022, bioRxiv.

Broad betacoronavirus neutralization by a stem helix–specific human antibody

M. Beltramello, A. Telenti, A. Walls, 2021, Science.

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

William T. Harvey, Kenneth G. C. Smith, A. Walls, 2021, medRxiv : the preprint server for health sciences.

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

M. Beltramello, A. Telenti, S. Whelan, 2021, bioRxiv.

Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae

M. Beltramello, A. Lanzavecchia, J. Suzich, 2017, Nature Communications.

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

William T. Harvey, Kenneth G. C. Smith, A. Walls, 2021, Nature.

Chronic Delivery of Antibody Fragments Using Immunoisolated Cell Implants as a Passive Vaccination Tool

R. Gruetter, C. Sandi, M. Cordero, 2011, PloS one.

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies

Kenneth G. C. Smith, A. Walls, D. Veesler, 2021 .

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

M. Beltramello, A. Telenti, S. Whelan, 2021, Cell.

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

M. Beltramello, F. Baldanti, E. Harris, 2016, Science.

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

A. Telenti, A. Walls, D. Veesler, 2021, Science.

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

P. Collins, J. Skehel, F. Sallusto, 2016, Cell.

ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies

L. Purcell, B. Weynand, A. Walls, 2022, bioRxiv.

Coronaviruses Hijack the LC3-I-Positive EDEMosomes, ER-Derived Vesicles Exporting Short-Lived ERAD Regulators, for Replication

Fulvio Reggiori, Maurizio Molinari, Riccardo Bernasconi, 2010, Cell Host & Microbe.

SARS-CoV-2 immune evasion by variant B.1.427/B.1.429

A. Telenti, A. Walls, D. Veesler, 2021, bioRxiv.

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

F. Baldanti, F. Sallusto, A. Lanzavecchia, 2013, Nature.

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

M. Beltramello, A. Telenti, M. Diamond, 2020, Nature.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae

M. Beltramello, A. Lanzavecchia, J. Suzich, 2017, Nature Communications.

Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies

A. Telenti, L. Purcell, A. Walls, 2021, bioRxiv.

A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery

M. Beltramello, A. Telenti, A. Walls, 2021, bioRxiv.

Alternative conformations of a major antigenic site on RSV F

J. McLellan, D. Corti, S. Bianchi, 2019, PLoS pathogens.

Retraction notice to: role of the SEL1L:LC3-I complex as an ERAD tuning receptor in the mammalian ER.

Fulvio Reggiori, Maurizio Molinari, Riccardo Bernasconi, 2014, Molecular cell.

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

P. Collins, J. Skehel, F. Sallusto, 2016, Cell.

1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness

D. Corti, A. Minola, S. Bianchi, 2020 .

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

J. Skehel, D. Jarrossay, F. Sallusto, 2011, Science.

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and 2 in vivo activity against SARS-CoV-2 3

L. Purcell, E. Cameroni, S. Bianchi, 2022 .